Does EVOLOCUMAB Cause Angina pectoris? 245 Reports in FDA Database
Lower Your Cholesterol — The Natural Way
The Oxidized Cholesterol Strategy: a science-backed plan for heart health.
According to the FDA Adverse Event Reporting System (FAERS), 245 reports of Angina pectoris have been filed in association with EVOLOCUMAB (REPATHA). This represents 0.2% of all adverse event reports for EVOLOCUMAB.
245
Reports of Angina pectoris with EVOLOCUMAB
0.2%
of all EVOLOCUMAB reports
10
Deaths
79
Hospitalizations
How Dangerous Is Angina pectoris From EVOLOCUMAB?
Of the 245 reports, 10 (4.1%) resulted in death, 79 (32.2%) required hospitalization, and 5 (2.0%) were considered life-threatening.
Is Angina pectoris Listed in the Official Label?
This adverse event is not currently listed in the official FDA drug label for EVOLOCUMAB. However, 245 reports have been filed with the FAERS database.
What Other Side Effects Does EVOLOCUMAB Cause?
Device difficult to use (31,807)
Drug dose omission by device (23,957)
Wrong technique in product usage process (21,664)
Accidental exposure to product (16,160)
Injection site pain (9,988)
Product storage error (6,606)
Back pain (5,254)
Myalgia (5,061)
Drug dose omission (4,914)
Injection site bruising (4,409)
What Other Drugs Cause Angina pectoris?
ASPIRIN (706)
ROSIGLITAZONE (680)
RANOLAZINE (583)
ATORVASTATIN (559)
AMLODIPINE (509)
RITUXIMAB (502)
CLOPIDOGREL BISULFATE (471)
SACUBITRIL\VALSARTAN (468)
PREDNISONE (462)
METFORMIN (452)
Which EVOLOCUMAB Alternatives Have Lower Angina pectoris Risk?
EVOLOCUMAB vs EXELON
EVOLOCUMAB vs EXEMESTANE
EVOLOCUMAB vs EXENATIDE
EVOLOCUMAB vs EXFORGE
EVOLOCUMAB vs EXJADE